In clinical trial data released this week, UK scientists have found evidence that liraglutide can reduce brain shrinkage and cognitive decline in Alzheimers patients
Health Canada has not approved BPC-157 as a health product or prescription drug, classifying it as an unauthorized health product
To view a copy of this licence, visit About this article Cite this article Pajaud, J., Ribault, C., Ben Mosbah, I
The best formulations combine effervescent delivery with additional technologies to protect the molecule and support cellular uptake
To view a copy of this licence, visit About this article Cite this article Zeng, W., Wang, Q., Li, X